[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]

July 2020 - July 1883

Decade

Year

Issue

July 14, 2020, Vol 324, No. 2, Pages 121-206

In This Issue of JAMA

Audio Highlights

Abstract Full Text
free access online only has audio
JAMA. 2020;324(2):e200028. doi:10.1001/jama.2020.0028
Original Investigation

Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia–Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial

Abstract Full Text
has active quiz
JAMA. 2020;324(2):157-167. doi:10.1001/jama.2020.8896

This randomized clinical trial compares the effects of maternal docosahexaenoic acid supplementation from childbirth through 36 weeks’ postmenstrual age vs placebo on bronchopulmonary dysplasia–free survival in breastfed infants born before 29 weeks of gestation.

Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality

Abstract Full Text
free access
JAMA. 2020;324(2):168-177. doi:10.1001/jama.2020.11301

This cohort study uses Danish registry data to estimate the association between a prescription for angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) in the 6 months prior to a coronavirus disease 2019 (COVID-19) diagnosis and mortality among all patients and those with hypertension.

Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis

Abstract Full Text
has active quiz
JAMA. 2020;324(2):179-187. doi:10.1001/jama.2020.8228

This meta-analysis uses individual participant data from clinical trials to estimate associations between radial artery vs saphenous vein grafting techniques and cardiovascular outcomes at 10 years among patients undergoing coronary artery bypass grafting (CABG).

Research Letter

Hospital-Wide SARS-CoV-2 Antibody Screening in 3056 Staff in a Tertiary Center in Belgium

Abstract Full Text
free access has active quiz
JAMA. 2020;324(2):195-197. doi:10.1001/jama.2020.11160

This study characterizes the prevalence of antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among hospital staff of a Belgian tertiary care center tested over 1 week in April 2020, and risk factors for seropositivity.

Changes in Hospital-Based Obstetric Services in Rural US Counties, 2014-2018

Abstract Full Text
JAMA. 2020;324(2):197-199. doi:10.1001/jama.2020.5662

This study describes hospital-based obstetric service losses in rural US counties between 2014 and 2018 overall and by county population and urban adjacency.

Viewpoint

Monoclonal Antibodies for Prevention and Treatment of COVID-19

Abstract Full Text
free access has multimedia
JAMA. 2020;324(2):131-132. doi:10.1001/jama.2020.10245

This Viewpoint discusses the potential role of neutralizing monoclonal antibodies (MAbs) as a treatment for coronavirus disease 2019 (COVID-19) and as a means of prevention in high-risk populations, and it also raises possible limitations of the approach that need to be disproven or addressed for the strategy to be effective.

COVID-19: Beyond Tomorrow

The Urgency and Challenge of Opening K-12 Schools in the Fall of 2020

Abstract Full Text
free access has active quiz has multimedia has audio
JAMA. 2020;324(2):133-134. doi:10.1001/jama.2020.10175

This Viewpoint proposes a policy framework for reopening of US primary, middle, and high schools (kindergarten through 12th grade) in fall 2020, including ramping up community public health responses in the summer, symptom screening of students, and privileging return-to-school decisions for younger children and others at risk for education disparities.

COVID-19: Beyond Tomorrow

Medicaid and COVID-19: At the Center of Both Health and Economic Crises

Abstract Full Text
free access
JAMA. 2020;324(2):135-136. doi:10.1001/jama.2020.10553

This Viewpoint discusses the financial pressures placed on US state budgets from the likely growth of Medicaid rolls during the COVID-19 pandemic, and proposes financing and policy adjustments to assist states in providing lifeline health care to low-income individuals during the crisis.

COVID-19: Beyond Tomorrow

Sustaining Rural Hospitals After COVID-19: The Case for Global Budgets

Abstract Full Text
has active quiz
JAMA. 2020;324(2):137-138. doi:10.1001/jama.2020.9744

This Viewpoint proposes that global budgets, or fixed payments for care of a population over a specific time, are well suited to address the financial instability wrought by the COVID-19 pandemic on rural hospitals, removing the link between volume and revenue and allowing them to adapt to community needs.

Making Decisions in a COVID-19 World

Abstract Full Text
free access has active quiz
JAMA. 2020;324(2):139-140. doi:10.1001/jama.2020.10178

This Viewpoint acknowledges the urgent need for answers to coronavirus-related public health questions such as individuals’ risk for coronavirus disease 2019 (COVID-19) exposure and disease if workplaces, schools, and businesses reopen, and emphasizes the need to translate cross-disciplinary science into usable form for policy decision makers, risk analysts, and the public.

Airborne Spread of SARS-CoV-2 and a Potential Role for Air Disinfection

Abstract Full Text
free access has active quiz has audio
JAMA. 2020;324(2):141-142. doi:10.1001/jama.2020.7603

In the context of potential aerosol spread of SARS-CoV-2 infection, this Viewpoint argues for use of upper-room germicidal UV (GUV) fixtures as a means to disinfect circulating air and prevent spread of COVID-19 and other infections in health care settings.

Shortcomings in the US Pharmaceutical Supply Chain: Potential Risks Associated With International Manufacturing and Trade-Related Tariffs

Abstract Full Text
JAMA. 2020;324(2):143-144. doi:10.1001/jama.2020.1634

This Viewpoint discusses vulnerabilities in the US drug supply chain given a shift in manufacturing of pharmaceutical ingredients to other countries and calls for a system to identify high-value medications, forecast supplies and shortages, and incentivize domestic production.

Regulating Medicines in a Globalized World With Increased Recognition and Reliance Among Regulators: A National Academies Report

Abstract Full Text
JAMA. 2020;324(2):145-146. doi:10.1001/jama.2019.21793

This Viewpoint summarizes recommendations from a 2020 National Academies of Sciences, Engineering, and Medicine (NASEM) committee report on ways to improve regulatory oversight of drugs in an era of global pharmaceutical research and development.

Sustainability, Business, and Health

Abstract Full Text
has audio
JAMA. 2020;324(2):147-148. doi:10.1001/jama.2020.8714

This Viewpoint discusses examples of how many private sector businesses have aligned their core missions with civil and human rights and sustainability reforms, and emphasizes the importance of engaging the sector in achieving public health goals and accelerating worldwide recovery from the COVID-19 pandemic.

A Piece of My Mind

“Are You Wearing Your White Coat?”: Telemedicine in the Time of Pandemic

Abstract Full Text
free access
JAMA. 2020;324(2):149-150. doi:10.1001/jama.2020.10619

In this narrative medicine essay, a palliative medicine physician reflects on what is gained and lost in the turn toward telemedicine during the COVID-19 pandemic from a cornerstone belief that the in-person encounter is an anchoring condition for the patient-physician relationship.

Editorial

Thinking of Risk in the Era of COVID-19

Abstract Full Text
free access
JAMA. 2020;324(2):151-153. doi:10.1001/jama.2020.10242

Coronary Revascularization Strategies: Making Sense of Sparse, Limited-Quality Data

Abstract Full Text
JAMA. 2020;324(2):154-156. doi:10.1001/jama.2020.8548
JAMA Guide to Statistics and Methods

Use of Run-in Periods in Randomized Trials

Abstract Full Text
free access
JAMA. 2020;324(2):188-189. doi:10.1001/jama.2020.6463

This JAMA Guide to Statistics and Methods reviews the use of prerandomization run-in periods to improve treatment adherence and reduce loss to follow-up, and explains how they should be interpreted.

JAMA Insights

Caring for Women Who Are Planning a Pregnancy, Pregnant, or Postpartum During the COVID-19 Pandemic

Abstract Full Text
free access has active quiz
JAMA. 2020;324(2):190-191. doi:10.1001/jama.2020.8883

This JAMA Insights Clinical Update discusses what is known about the epidemiology and effects of SARS-CoV-2 infection in pregnancy, and summarizes Centers for Disease Control and Prevention (CDC) and professional organization (AAP and ACOG) recommendations for care of pregnant women with COVID-19.

From The Medical Letter on Drugs and Therapeutics

Peanut Allergen Powder (Palforzia)

Abstract Full Text
JAMA. 2020;324(2):192-193. doi:10.1001/jama.2020.3599

This Medical Letter review summarizes the dosing, administration, cost, and adverse effects use of peanut allergen powder-dnfp (Palforzia), an oral immunotherapy indicated to mitigate allergic reactions, including anaphylaxis, caused by accidental peanut exposure in patients with a confirmed peanut allergy.

Editor's Note

Renin-Angiotensin-Aldosterone Inhibitors and Susceptibility to and Severity of COVID-19

Abstract Full Text
free access
JAMA. 2020;324(2):177-178. doi:10.1001/jama.2020.11401
Medical News & Perspectives

“Abandoned” Nursing Homes Continue to Face Critical Supply and Staff Shortages as COVID-19 Toll Has Mounted

Abstract Full Text
free access has audio
JAMA. 2020;324(2):123-125. doi:10.1001/jama.2020.10419

This Medical News article discusses nursing homes’ ongoing challenges during the novel coronavirus pandemic.

The JAMA Forum

Resilience in Health Care Financing

Abstract Full Text
free access
JAMA. 2020;324(2):126-127. doi:10.1001/jama.2020.10417
News From the Centers for Disease Control and Prevention

Norovirus Spread Among Hundreds of 2018 California Fire Evacuees

Abstract Full Text
free access
JAMA. 2020;324(2):129. doi:10.1001/jama.2020.11551

Connecting Refugees With Follow-up Care for Hepatitis B

Abstract Full Text
free access
JAMA. 2020;324(2):129. doi:10.1001/jama.2020.10632
Biotech Innovations

Autologous Brain Cell Transplant for Parkinson Disease

Abstract Full Text
free access
JAMA. 2020;324(2):128. doi:10.1001/jama.2020.11581

Researchers Home in on COVID-19 Severity Biomarkers

Abstract Full Text
free access
JAMA. 2020;324(2):128. doi:10.1001/jama.2020.11397

COVID-19 Antibody Trials Have Begun

Abstract Full Text
free access
JAMA. 2020;324(2):128. doi:10.1001/jama.2020.11582
Poetry and Medicine

Morning Report—: To a Poet Who Thinks He Understands

Abstract Full Text
free access
JAMA. 2020;324(2):202. doi:10.1001/jama.2020.0121
JAMA Revisited

Prohibition and the Medical Profession

Abstract Full Text
free access
JAMA. 2020;324(2):203. doi:10.1001/jama.2019.13521
JAMA Patient Page

What Is Anosmia?

Abstract Full Text
free access
JAMA. 2020;324(2):206. doi:10.1001/jama.2020.10966

This JAMA Patient Page describes the causes, diagnosis, and treatment options for anosmia and olfactory dysfunction.

Comment & Response

Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery

Abstract Full Text
JAMA. 2020;324(2):199. doi:10.1001/jama.2020.6980

Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery

Abstract Full Text
JAMA. 2020;324(2):199. doi:10.1001/jama.2020.6971

Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery

Abstract Full Text
JAMA. 2020;324(2):199-200. doi:10.1001/jama.2020.6977

Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery

Abstract Full Text
JAMA. 2020;324(2):200. doi:10.1001/jama.2020.6974

Hydroxyethyl Starch vs Saline for Volume Expansion After Abdominal Surgery—Reply

Abstract Full Text
JAMA. 2020;324(2):200-201. doi:10.1001/jama.2020.6983
JAMA Masthead

JAMA

Abstract Full Text
free access
JAMA. 2020;324(2):121-122. doi:10.1001/jama.2019.13514
×